Table 3.
Median antifilarial IgG levels for the 126 persons in the Mapou cohort who received antifilarial drug treatment in 2000 and the 34 who did not, by year
| Antifilarial Antibody Level* | ||||
| Treatment status | 2000 | 2001 | ||
| Received treatment | Median (interquartile range) | Median (interquartile range) | p-value | |
| IgG1 | 68.5 (22.2–147.5) | 43.0 (20.9–85.6) | 0.001 | |
| IgG4 | 57.5 (29.9–98.3) | 55.9 (21.0–65.9) | 0.067 | |
| Did not receive treatment | ||||
| IgG1 | 64.5 (31.9–157.0) | 100.0 (52.3–169.7) | 0.101 | |
| IgG4 | 61.5 (45.6–104.6) | 96.4 (52.40–216.0) | 0.088 | |
*units